UK Markets open in 5 hrs 29 mins

Mister Spex SE (MRX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
12.02-0.09 (-0.74%)
At close: 08:46AM CET
Full screen
Previous close12.11
Open12.02
Bid12.11 x N/A
Ask12.41 x N/A
Day's range12.02 - 12.02
52-week range12.01 - 26.08
Volume55
Avg. volume266
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Mister Spex SE continues double-digit growth in third quarter of 2021

    DGAP-News: Mister Spex SE / Key word(s): Quarter Results24.11.2021 / 07:30 The issuer is solely responsible for the content of this announcement.Berlin, 24 November 2021Mister Spex SE continues double-digit growth in third quarter of 2021 Growth in the sunglasses and contact lenses product categories leads to overall 11% revenue increase in the third quarter 2021 With 35% growth compared to the third quarter of 2019, Mister Spex is outperforming the market Number of active customers increased by

  • EQS Group

    Mister Spex SE: Adjustment of full year 2021 guidance

    Mister Spex SE / Key word(s): Change in ForecastMister Spex SE: Adjustment of full year 2021 guidance01-Nov-2021 / 21:43 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Berlin, 1 November 2021Mister Spex SE: Adjustment of full year 2021 guidanceThe management board of Mister Spex SE, the leading digitally-driven omnichnannel

  • EQS Group

    Mister Spex SE grows strongly by 25 percent in the first half of 2021

    DGAP-News: Mister Spex SE / Key word(s): Half Year Results22.09.2021 / 07:30 The issuer is solely responsible for the content of this announcement.Berlin, 22 September 2021Mister Spex SE grows strongly by 25 percent in the first half of 2021 Revenue growth of 25% to 101 million euros driven by solid growth in both segments the German market +26% and International Markets +24% Revenues with prescription glasses increased 32% in line with the strategic focus Adjusted EBITDA1 increased slightly by